Aerovate Therapeutics Inc

NASDAQ:AVTE   4:00:00 PM EDT
22.50
-1.12 (-4.74%)
4:01:36 PM EDT: $22.50 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aerovate Therapeutics Inc Stock, NASDAQ:AVTE

930 Winter Street, Suite M-500, Waltham, Massachusetts 02451
United States of America
Phone: +1.617.443.2400
Number of Employees: 51
http://www.aerovatetx.com

Description

Aerovate Therapeutics, Inc. is a biotechnology company which engages in the development of drugs for rare cardiopulmonary disease. It focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension. The company was founded by Benjamin T. Dake on July 27, 2018 and is headquartered in Waltham, MA.